期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

LOX-1对急性冠脉综合征的早期预测价值 被引量：3

暂未订购
导出
摘要 目的:探讨血凝素样氧化低密度脂蛋白受体-1(LOX-1)对急性冠脉综合征的早期预测价值。方法:选择行冠脉动脉造影的患者75例,根据临床情况分为正常对照组(NC组)22例、不稳定型心绞痛组(UA组)28例和急性心肌梗死组(AMI组)25例,根据SYNTAX积分分为高危组(19例)和低危组(34例)。采用酶联免疫法测定患者血清LOX-1水平。结果:AMI组LOX-1水平高于UA组和NC组,UA组LOX-1水平高于NC组,差异均有统计学意义(P<0.05或P<0.01)。高危组患者LOX-1水平(107.43±35.18)ng/L高于低危组(86.90±31.27)ng/L,差异有统计学意义(t=2.19,P<0.05)。结论:LOX-1是预测急性冠脉综合征很有潜力的生物学标志物。
作者 王硕莹 刘洪梅 倪燕平 刘相丽
机构地区 天津医科大学研究生院 天津医科大学第二医院心脏科
出处 《天津医药》 CAS 北大核心 2012年第7期716-717,共2页 Tianjin Medical Journal
关键词 脂蛋白类 LDL 血凝素样氧化低密度脂蛋白受体-1 急性冠状动脉综合征 动脉粥样硬化 SYN-TAX评分
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献1

二级参考文献20

  • 1Ryan TJ, Faxon DE Gunnar RM, Kennedy JW, King SB, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American college of cardiology/American heart association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty). Circulation 1988; 78: 486-502.
  • 2Ellis SG, Vandormael MG, Cowley MJ, Whitlow PL, Schneider JP, Topol EJ. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990; 82:1193-1202.
  • 3Hamburger JN, Serruys PW, Scabra-Gomes R, Simon R, Koolen J J, Fleck E, et al. Recanalization of total coronary occlusions using a laser guidewire (the European TOTAL Surveillance Study). Am J Cardiol 1997; 80: 1419-1423.
  • 4Iwakura K, Ito H, Ikushima M, Okamura A, Asano K, Kuroda T, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1-7.
  • 5Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A, et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000; 49: 274-283.
  • 6Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
  • 7Gyongyosi M, Christ G, Lang I, Kreiner G, Sochor H, Probst E et al. Two-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy.between percutaneous coronary intervention with TAXUS and cardiac surgery) study. JACC Cardiovasc Interv 2009; 2: 718-727.
  • 8Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern M J, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001; 103: 3019-3041.
  • 9Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937-948.
  • 10Kirtane A J, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-elating and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206.

共引文献17

同被引文献28

引证文献3

二级引证文献7

天津医药
2012年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部